VKTX
Viking Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.99
−1.26%Next report
Analyst consensus
- Next report date
- Oct 28, 2026
- EPS estimate
- -$1.07
- Revenue estimate
- —
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- -$1.10
- EPS estimate
- -$1.23
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -24.0%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $90
- PT range
- $65 – $114
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | -$1.23 | -$1.10 | Beat 10.57% | — |
| Apr 29, 2026 | -$1.01 | -$1.37 | Miss -35.64% | — |
| Feb 11, 2026 | -$0.89 | -$1.38 | Miss -55.06% | — |
| Oct 22, 2025 | -$0.70 | -$0.81 | Miss -15.71% | — |
| Jul 23, 2025 | -$0.44 | -$0.58 | Miss -31.82% | — |
| Apr 23, 2025 | -$0.34 | -$0.41 | Miss -20.59% | — |
| Feb 5, 2025 | -$0.28 | -$0.32 | Miss -14.29% | — |
| Oct 23, 2024 | -$0.24 | -$0.22 | Beat 8.33% | — |
| Jul 24, 2024 | -$0.26 | -$0.20 | Beat 23.08% | — |
| Feb 7, 2024 | -$0.25 | -$0.25 | In line | $436.0K |
| Oct 25, 2023 | -$0.22 | -$0.23 | Miss -4.55% | — |
| Jul 26, 2023 | -$0.21 | -$0.19 | Beat 9.52% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026